中国学者近期发表的论文
1.	MDR1 gene polymorphism correlated with pathological characteristics and prognosis in patients with primary hepatocellular carcinoma receiving interventional therapy. Author: Hu W1, Huang S, Dong L, Yu C, Li C, Zhang J. Journal: Anticancer Drugs. 2019 Mar;30(3):233-240. doi: 10.1097/CAD.0000000000000680.    PubMed      DOI
2.	Evodiamine inhibits migration and invasion by Sirt1-mediated post-translational modulations in colorectal cancer. Author: Zhou P1,2,3,4, Li XP1, Jiang R1, Chen Y1, Lv XT1, Guo XX1, Tian K1, Yuan DZ1, Lv YW1, Ran JH1, Li J1, Chen DL1,2,3,4,5. Journal: Anticancer Drugs. 2019 Jul;30(6):611-617. doi: 10.1097/CAD.0000000000000760.    PubMed      DOI
3.	Formylated honokiol analogs showed antitumor activity against lung carcinoma. Author: Deng S1,2, Zhang C2, Yang L1, Ma L1. Journal: Anticancer Drugs. 2019 Feb 21. doi: 10.1097/CAD.0000000000000771. [Epub ahead of print]    PubMed      DOI
4.	Preparation of truncated tissue factor antineuropilin-1 monoclonal antibody conjugate and identification of its selective thrombosis in tumor blood vessels. Author: Xu P1, Zou M, Wang S, Wang L, Wang L, Luo F, Wu T, Yan J. Journal: Anticancer Drugs. 2019 Jun;30(5):441-450. doi: 10.1097/CAD.0000000000000767.    PubMed      DOI
5.	PSMA5 promotes the tumorigenic process of prostate cancer and is related to bortezomib resistance. Author: Fu Z1, Lu C2, Zhang C1, Qiao B1. Journal: Anticancer Drugs. 2019 Feb 21. doi: 10.1097/CAD.0000000000000773. [Epub ahead of print]    PubMed      DOI
6.	Bufalin engages in RIP1-dependent and ROS-dependent programmed necroptosis in breast cancer cells by targeting the RIP1/RIP3/PGAM5 pathway. Author: Li Y1, Gong P, Kong C, Tian X. Journal: Anticancer Drugs. 2019 Mar 1. doi: 10.1097/CAD.0000000000000770. [Epub ahead of print]    PubMed      DOI
7.	Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy. Author: Mao J1, Meng X2, Zhao C2, Yang Y2, Liu G3. Journal: Anticancer Drugs. 2019 Jul;30(6):604-610. doi: 10.1097/CAD.0000000000000754.    PubMed      DOI
8.	C188-9, a small-molecule STAT3 inhibitor, exerts an antitumor effect on head and neck squamous cell carcinoma. Author: Di JX1, Zhang HY2. Journal: Anticancer Drugs. 2019 Mar 11. doi: 10.1097/CAD.0000000000000783. [Epub ahead of print]    PubMed      DOI
9.	Methylxanthine derivatives promote autophagy in gastric cancer cells targeting PTEN. Author: Liu H1, Song J, Zhou Y, Cao L, Gong Y, Wei Y, Yang H, Tang L. Journal: Anticancer Drugs. 2019 Apr;30(4):347-355. doi: 10.1097/CAD.0000000000000724.    PubMed      DOI
10.	Oleanolic acid inhibits cell proliferation migration and invasion and induces SW579 thyroid cancer cell line apoptosis by targeting forkhead transcription factor A. Author: Duan L1, Yang Z1, Jiang X1, Zhang J2, Guo X3. Journal: Anticancer Drugs. 2019 Mar 14. doi: 10.1097/CAD.0000000000000777. [Epub ahead of print]    PubMed      DOI

同类著名期刊名称 h-index CiteScore PHARMACOLOGICAL REVIEWS 210 18.73 TRENDS IN PHARMACOLOGICAL SCIENCES 201 9.98 ADVANCED DRUG DELIVERY REVIEWS 278 13.90 DRUG RESISTANCE UPDATES 100 13.15 PHARMACOLOGY & THERAPEUTICS 180 10.16 MEDICINAL RESEARCH REVIEWS 119 8.83 BRITISH JOURNAL OF PHARMACOLOGY 190 6.12 DRUG DISCOVERY TODAY 157 7.08 CLINICAL PHARMACOLOGY & THERAPEUTICS 173 4.47 PHARMACOLOGICAL RESEARCH 118 5.27

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 283219 CANCER RESEARCH 163416 International Journal of Nanomedicine 161787 Molecular Medicine Reports 161566 CANCER LETTERS 156850 JOURNAL OF ETHNOPHARMACOLOGY 138687 BIOMEDICINE & PHARMACOTHERAPY 136534 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 133301 Theranostics 132486 International Journal of Environmental Research and Public Health 130964